Christopher McGuigan
Plus aucun poste en cours
Profil
Christopher McGuigan served as a Vice President at BP Amoco Corp.
and as a Deputy Vice Chancellor at the University of Cardiff from 1994 to 2016.
He was also a Founding Director & Chief Scientific Officer at Cardiff Protides Ltd.
and a Director at Muscagen Ltd.
and FermaVir Pharmaceuticals LLC.
Additionally, he served as a Director for The International Society for Antiviral Research and as a Chairman for Life Sciences.
Hub Wales Ltd.
He was a Professor at the Welsh School of Pharmacy.
McGuigan also held various independent director positions at companies such as Synergy Pharmaceuticals LLC, Tiziana Life Sciences Ltd.
(United Kingdom), Hepion Pharmaceuticals, Inc., and Cardiff Oncology, Inc. He was a Non-Executive Director at Tiziana Life Sciences Ltd.
(United Kingdom) and served as the Chief Scientific Officer at NuCana Plc from 2015 to 2016.
McGuigan received his undergraduate and doctorate degrees from the University of Birmingham.
Anciens postes connus de Christopher McGuigan
| Sociétés | Poste | Fin |
|---|---|---|
| University of Cardiff | Corporate Officer/Principal | 11/03/2016 |
| HEPION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/03/2016 |
| Welsh School of Pharmacy | Corporate Officer/Principal | 11/03/2016 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 11/03/2016 |
Life Sciences Hub Wales Ltd.
 Life Sciences Hub Wales Ltd. Information Technology ServicesTechnology Services Life Sciences Hub Wales Ltd. is an innovation project management support company based in Cardiff Bay, UK. The British company's experienced and skilled team helps progress work towards transforming the health and economic wellbeing of the nation. The private company provides support in producing business cases that drive innovation projects towards clinical adoption. Life Sciences Hub Wales is an arm’s length body of Welsh Government that catalyses innovation and collaboration between industry, health, social care, and academia, making a positive difference to people, families, and businesses across the nation. The CEO of the company is Cari-Anne Quinn. | Président | 11/03/2016 |
Formation de Christopher McGuigan
| University of Birmingham | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| NUCANA PLC | Health Technology |
| Entreprise privées | 11 |
|---|---|
BP Amoco Corp.
 BP Amoco Corp. Oil & Gas ProductionEnergy Minerals BP Amoco Corp. provides oil and gas exploration services. The firm offers engineering, procurement and construction services for gas-fired co-generation facilities. The company was founded on March 11, 1987 and is headquartered in Houston, TX. | Energy Minerals |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Health Technology |
| Cardiff Protides Ltd. | Commercial Services |
Muscagen Ltd.
 Muscagen Ltd. Pharmaceuticals: GenericHealth Technology Muscagen Ltd. operates as biotechnology company. It develops therapeutic drugs for the treatment of urinary incontinence, heart attack, and alzheimer's disease. The company was founded on October 13, 2000 and is headquartered in London, the United Kingdom. | Health Technology |
The International Society for Antiviral Research
 The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services The International Society for Antiviral Research operates an institution for the sharing of scientific developments in antiviral medicines. The private company is based in Logan, UT. | Commercial Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Life Sciences Hub Wales Ltd.
Life Sciences Hub Wales Ltd. Information Technology ServicesTechnology Services Life Sciences Hub Wales Ltd. is an innovation project management support company based in Cardiff Bay, UK. The British company's experienced and skilled team helps progress work towards transforming the health and economic wellbeing of the nation. The private company provides support in producing business cases that drive innovation projects towards clinical adoption. Life Sciences Hub Wales is an arm’s length body of Welsh Government that catalyses innovation and collaboration between industry, health, social care, and academia, making a positive difference to people, families, and businesses across the nation. The CEO of the company is Cari-Anne Quinn. | Technology Services |
| Life Sciences Research Network Wales | |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
